N2Growth Blog
OCTOBER 23, 2023
With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. This ability to bridge the gap between science and strategy is crucial in such a highly dynamic space.
Strategy Driven
MAY 12, 2021
Another technique uses a unique eye-sensing technology that constantly senses the position of your eyes and delivers a bright, clear 3D image to each one. A proprietary high-speed sensor follows your eye’s movement down to the millisecond, sensing pupil position through space on all three axes: vertical, horizontal, and even depth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Harvard Business Review
SEPTEMBER 21, 2018
Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.
Harvard Business Review
MARCH 11, 2014
That is, why bother trying to innovate if no matter what they do, large companies can no longer maintain a sustainable advantage and their life spans are just getting shorter and shorter? In these markets if existing companies don’t rise to the innovation challenge, no one will. “Why bother?”.
Harvard Business Review
OCTOBER 1, 2014
The implicit axiom here is that robust companies that have sustained and grown over the longer term are somehow less innovative. And Alibaba is a 16 year-old company, and no one is claiming it is sluggish or un-innovative.)
Harvard Business Review
OCTOBER 26, 2011
Their behavior displays promising parallels to the early days of the biotechnology industry. When biotechnology startups like Genentech began to acquire other startups to retain their edge, pharmaceutical incumbents were forced to enter the acquisition melee to remain competitive.
Harvard Business Review
MARCH 8, 2013
government, which through DARPA and other initiatives stands out worldwide for its astoundingly positive track record in funding true innovation. It is not by accident that the National Institutes of Health spends $31 billion a year on supporting innovation in biotechnology and pharmacology. Consider Apple.
Expert insights. Personalized for you.
416 
Let's personalize your content